Agilent Slates Asia Tour for Gene Expression Products | GenomeWeb

Agilent is preparing two road show tours to Asia this spring, visiting Japan in April, and then taking another jaunt in May, with first stops in Guangzhou, and Shanghai, China, then heading to Taiwan and Singapore, before finishing in Melbourne and Brisbane, Australia.

The road show will include three presentations in half-day events, one from a customer and two from Agilent representatives, as the company makes an effort to promote its gene-expression lines in a marketplace that is regarded as under-exploited and perhaps primed for business.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.